Free Trial
Joon Lee

Joon Lee Analyst Performance

Managing Director, Biotech Analyst at Truist Financial

Joon Lee is a stock analyst at Truist Financial in the medical sector, covering 20 publicly traded companies. Over the past year, Joon Lee has issued 20 stock ratings, including buy and hold recommendations. While full access to Joon Lee's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Joon Lee's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
31 Last 5 Years
Buy Recommendations
92.86% 26 Buy Ratings
Companies Covered
20 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy92.9%26 ratings
Hold7.1%2 ratings
Sell0.0%0 ratings

Out of 28 total stock ratings issued by Joon Lee at Truist Financial, the majority (92.9%) have been Buy recommendations, followed by 7.1% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
20 companies

Joon Lee, an analyst at Truist Financial, currently covers 20 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
20 companies
100.0%

Joon Lee of Truist Financial specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
15 companies
75.0%
MED - DRUGS
4 companies
20.0%
PHARMACEUTICAL PREPARATIONS
1 company
5.0%

Joon Lee's Ratings History at Truist Financial

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Rapport Therapeutics, Inc. stock logo
RAPP
Rapport Therapeutics
9/16/2025Initiated Coverage$24.73$44.00Buy
argenex SE stock logo
ARGX
argenex
9/15/2025Boost Price Target$756.38$918.00Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
8/5/2025Set Price Target$392.94$490.00Buy
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
7/29/2025Boost Price Target$49.79$86.00Buy
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
6/17/2025Initiated Coverage$51.87$80.00Buy
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
6/17/2025Set Price Target$9.07$9.00Hold
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
5/6/2025Set Price Target$70.46$135.00
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
4/28/2025Reiterated Rating$25.54$75.00Buy
Arvinas, Inc. stock logo
ARVN
Arvinas
4/9/2025Lower Price Target$6.19$21.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
3/31/2025Boost Price Target$102.71$150.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
3/4/2025Lower Price Target$8.98$50.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
3/3/2025Lower Price Target$37.71$85.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
2/19/2025Boost Price Target$125.57$200.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
2/12/2025Boost Price Target$42.39$120.00Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/11/2025Boost Price Target$460.13$520.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
2/3/2025Boost Price Target$106.86$190.00Buy
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
1/29/2025Initiated Coverage$3.48$18.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
1/21/2025Boost Price Target$74.33$175.00Buy
argenex SE stock logo
ARGX
argenex
1/14/2025Reiterated Rating$673.54$700.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
1/13/2025Boost Price Target$80.05$180.00Buy